These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

208 related items for PubMed ID: 2530281

  • 1. Mechanism of action of anti-IL-2R monoclonal antibodies. ART-18 prolongs cardiac allograft survival in rats by elimination of IL-2R+ mononuclear cells.
    Tanaka K, Hancock WW, Osawa H, Stunkel KG, Alberghini TV, Diamantstein T, Tilney NL, Kupiec-Weglinski JW.
    J Immunol; 1989 Nov 01; 143(9):2873-9. PubMed ID: 2530281
    [Abstract] [Full Text] [Related]

  • 2. Selective immunosuppression with anti-interleukin 2 receptor-targeted therapy: helper and suppressor cell activity in rat recipients of cardiac allografts.
    Kupiec-Weglinski JW, Padberg W, Uhteg LC, Ma L, Lord RH, Araneda D, Strom TB, Diamantstein T, Tilney NL.
    Eur J Immunol; 1987 Mar 01; 17(3):313-9. PubMed ID: 2952511
    [Abstract] [Full Text] [Related]

  • 3. Identification of IL 2R+ T cells and macrophages within rejecting rat cardiac allografts, and comparison of the effects of treatment with anti-IL 2R monoclonal antibody or cyclosporin.
    Hancock WW, Lord RH, Colby AJ, Diamantstein T, Rickles FR, Dijkstra C, Hogg N, Tilney NL.
    J Immunol; 1987 Jan 01; 138(1):164-70. PubMed ID: 3097143
    [Abstract] [Full Text] [Related]

  • 4. Differential T cell hyporesponsiveness induced by in vivo administration of intact or F(ab')2 fragments of anti-CD3 monoclonal antibody. F(ab')2 fragments induce a selective T helper dysfunction.
    Hirsch R, Archibald J, Gress RE.
    J Immunol; 1991 Oct 01; 147(7):2088-93. PubMed ID: 1833451
    [Abstract] [Full Text] [Related]

  • 5. Blocking of interleukin 2 (IL 2) binding to the IL 2 receptor is not required for the in vivo action of anti-IL 2 receptor monoclonal antibody (mAb). I. The production, characterization and in vivo properties of a new mouse anti-rat IL 2 receptor mAb that reacts with an epitope different to the one that binds to IL 2 and the mAb ART-18.
    Mouzaki A, Volk HD, Osawa H, Diamantstein T.
    Eur J Immunol; 1987 Mar 01; 17(3):335-41. PubMed ID: 3106058
    [Abstract] [Full Text] [Related]

  • 6. Differential effects of interleukin 2 receptor-targeted therapy on heart and kidney allografts in rats. Depression of effectiveness of ART-18 monoclonal antibody treatment by uremia.
    Ueda H, Hancock WW, Cheung YC, Tanaka K, Kupiec-Weglinski JW, Tilney NL.
    Transplantation; 1990 Jun 01; 49(6):1124-9. PubMed ID: 2113725
    [Abstract] [Full Text] [Related]

  • 7. Pretreatment with cyclosporine and anti-interleukin 2 receptor antibody abrogates the anti-idiotype response in rat recipients of cardiac allografts.
    Tanaka K, Tilney NL, Stunkel KG, Hancock WW, Diamantstein T, Kupiec-Weglinski JW.
    Proc Natl Acad Sci U S A; 1990 Oct 01; 87(19):7375-9. PubMed ID: 2217171
    [Abstract] [Full Text] [Related]

  • 8. Treatment of murine lupus with F(ab')2 fragments of monoclonal antibody to L3T4. Suppression of autoimmunity does not depend on T helper cell depletion.
    Carteron NL, Schimenti CL, Wofsy D.
    J Immunol; 1989 Mar 01; 142(5):1470-5. PubMed ID: 2521880
    [Abstract] [Full Text] [Related]

  • 9. CD4 mAb therapy modulates alloantibody production and intracardiac graft deposition in association with selective inhibition of Th1 lymphokines.
    Kupiec-Weglinski JW, Wasowska B, Papp I, Schmidbauer G, Sayegh MH, Baldwin WM, Wieder KJ, Hancock WW.
    J Immunol; 1993 Nov 01; 151(9):5053-61. PubMed ID: 8409456
    [Abstract] [Full Text] [Related]

  • 10. Evidence that monoclonal antibodies against the 55kD subunit of the rat IL-2 receptor do not inhibit the development of suppressor cells generated in mixed lymphocyte culture.
    Tanaka K, Turka LA, Kupiec-Weglinski JW, Milford EL, Ueda H, Diamantstein T, Carpenter CB, Tilney NL.
    Transplantation; 1990 Jul 01; 50(1):125-31. PubMed ID: 2142344
    [Abstract] [Full Text] [Related]

  • 11. Humanized antibody directed to the IL-2 receptor beta-chain prolongs primate cardiac allograft survival.
    Tinubu SA, Hakimi J, Kondas JA, Bailon P, Familletti PC, Spence C, Crittenden MD, Parenteau GL, Dirbas FM, Tsudo M.
    J Immunol; 1994 Nov 01; 153(9):4330-8. PubMed ID: 7930631
    [Abstract] [Full Text] [Related]

  • 12. Induction of nonspecific x-irradiation-resistant suppressor cell activity in vivo and prolongation of vascularized allograft survival by SK&F 105685, a novel immunomodulatory azaspirane.
    Schmidbauer G, Hancock WW, Badger AM, Kupiec-Weglinski JW.
    Transplantation; 1993 Jun 01; 55(6):1236-43. PubMed ID: 8516808
    [Abstract] [Full Text] [Related]

  • 13. Inhibition of anti-IgM and growth factor-induced proliferation of guinea pig B cells by one of two distinct Fc gamma receptors on the cells.
    Yamashita T, Koyama J.
    J Immunol; 1988 Nov 01; 141(9):2889-94. PubMed ID: 2971734
    [Abstract] [Full Text] [Related]

  • 14. Biodistribution of anti-interleukin 2 receptor monoclonal antibodies correlates with their therapeutic efficacy following transplantation.
    Kupiec-Weglinski JW, Mariani G, Tanaka K, Di Stefano R, Stünkel KG, Diamantstein T, Tilney NL.
    Cell Immunol; 1989 Oct 01; 123(1):148-57. PubMed ID: 2476241
    [Abstract] [Full Text] [Related]

  • 15. Administration of anti-interleukin-6 monoclonal antibody prolongs cardiac allograft survival.
    Lei J, He F, Wu M, Zheng X, Chen X, Chen Z.
    Transpl Int; 2010 Dec 01; 23(12):1271-81. PubMed ID: 20646257
    [Abstract] [Full Text] [Related]

  • 16. Pretreatment with cyclosporin A (CyA) and anti-interleukin 2 receptor monoclonal antibody (IL-2R MAb) abrogates the anti-idiotype response in rat recipients of cardiac allografts.
    Tanaka K, Kupiec-Weglinski JW, Hancock WW, Stunkel K, Diamantstein T, Tilney NL.
    Transplant Proc; 1991 Feb 01; 23(1 Pt 1):281-2. PubMed ID: 1990532
    [No Abstract] [Full Text] [Related]

  • 17. Administration of F(ab')2 fragments of monoclonal antibody to L3T4 inhibits humoral immunity in mice without depleting L3T4+ cells.
    Gutstein NL, Wofsy D.
    J Immunol; 1986 Dec 01; 137(11):3414-9. PubMed ID: 3097122
    [Abstract] [Full Text] [Related]

  • 18. Production of antiidiotypic antibodies in the rat: in vitro characterization of specificity and correlation with in vivo specific suppression of cardiac allograft immune reaction across major histocompatibility complex.
    Wasfie T, Reed E, Suciu-Foca N, Hardy MA.
    Surgery; 1990 Aug 01; 108(2):431-40; discussion 440-1. PubMed ID: 2143319
    [Abstract] [Full Text] [Related]

  • 19. Four epitopes on the rat 55-kDa subunit of the interleukin 2 receptor as defined by newly developed mouse anti-rat interleukin 2 receptor monoclonal antibodies.
    Mouzaki A, Diamantstein T.
    Eur J Immunol; 1987 Nov 01; 17(11):1661-4. PubMed ID: 2445587
    [Abstract] [Full Text] [Related]

  • 20. Agonistic and antagonistic interactions of anti-interleukin 2 receptor monoclonal antibodies in rat recipients of cardiac allografts.
    Kupiec-Weglinski JW, Tilney NL, Stunkel KG, Grutzmann R, van der Meide PH, Di Stefano R, Diamantstein T.
    Transplantation; 1989 Jan 01; 47(1):11-6. PubMed ID: 2463699
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.